61 related articles for article (PubMed ID: 9135741)
1. A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancers.
Evans TJ; Brooks L; Farrell PJ
Gene Ther; 1997 Mar; 4(3):264-7. PubMed ID: 9135741
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of Epstein-Barr virus from latency.
Amon W; Farrell PJ
Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
[TBL] [Abstract][Full Text] [Related]
4. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
Van Scoy S; Watakabe I; Krainer AR; Hearing J
Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
[TBL] [Abstract][Full Text] [Related]
5. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
Wendelburg BJ; Vos JM
Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
[TBL] [Abstract][Full Text] [Related]
6. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
7. Regulation of transcription by the Epstein-Barr virus nuclear antigen EBNA 2.
Palermo RD; Webb HM; Gunnell A; West MJ
Biochem Soc Trans; 2008 Aug; 36(Pt 4):625-8. PubMed ID: 18631129
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
Kelly G; Bell A; Rickinson A
Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated cancers: aetiology and treatment.
Lopes V; Young LS; Murray PG
Herpes; 2003 Dec; 10(3):78-82. PubMed ID: 14759340
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
13. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and cancers of the head and neck.
Goldenberg D; Golz A; Netzer A; Rosenblatt E; Rachmiel A; Goldenberg RF; Joachims HZ
Am J Otolaryngol; 2001; 22(3):197-205. PubMed ID: 11351290
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
Hui KF; Tam KP; Chiang AKS
Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
[TBL] [Abstract][Full Text] [Related]
17. [Epstein-Barr virus].
Niller HH; Wolf H
Zentralbl Hyg Umweltmed; 1993 Feb; 194(1-2):118-25. PubMed ID: 8392849
[TBL] [Abstract][Full Text] [Related]
18. [Epstein-Barr virus-associated diseases--from infectious mononucleosis to malignant neoplasms].
Kuroda M; Imai S
Nihon Rinsho; 2003 Feb; 61 Suppl 2():222-8. PubMed ID: 12722218
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus genes and cancer cells.
Farrell PJ; Cludts I; Stühler A
Biomed Pharmacother; 1997; 51(6-7):258-67. PubMed ID: 9309246
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector.
Kaneda Y; Saeki Y; Nakabayashi M; Zhou WZ; Kaneda MW; Morishita R
Hum Gene Ther; 2000 Feb; 11(3):471-9. PubMed ID: 10697121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]